Literature DB >> 3306350

Reassessment of LAK phenomenology: a review.

E Lotzová, R B Herberman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3306350

Source DB:  PubMed          Journal:  Nat Immun Cell Growth Regul        ISSN： 0254-7600


× No keyword cloud information.
  8 in total

Review 1.  Bronchoalveolar lavage and the immunology of lung cancer.

Authors:  G Semenzato; M Spatafora; C Feruglio; E Pace; V Dipietro
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Cytotoxicity and clinical application of activated NK cells.

Authors:  E Lotzová
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Feeder cells enhance oncolytic and proliferative activity of long-term human bone marrow interleukin-2 cultures and induce different lymphocyte subsets.

Authors:  P R Fuchshuber; E Lotzová
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Induction of lymphokine-activated killer activity in mice by prothymosin alpha.

Authors:  C N Baxevanis; A D Gritzapis; G V Dedoussis; N G Papadopoulos; O Tsolas; M Papamichail
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

5.  Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer.

Authors:  S P Bugis; E Lotzová; H E Savage; J P Hester; T Racz; P G Sacks; S P Schantz
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assays.

Authors:  R P Junghans
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Antiviral effect of lymphokine-activated killer cells: chemotaxis and homing to sites of virus infection.

Authors:  R J Natuk; J F Bukowski; J O Brubaker; R M Welsh
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Cancer immunotherapy: potential involvement of mediators.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.